Vir Biotechnology's market cap is currently ―. The company's EPS TTM is $-3.923; its P/E ratio is ―; Vir Biotechnology is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Dec 23	Sep 23	Jun 23
Income Statement	-
Total Revenue	$ 2.38M	$ 3.08M	$ 9.60M	$ 2.64M	$ 3.80M
Gross Profit	$ 2.33M	$ 3.02M	$ 8.80M	$ 2.60M	$ 3.77M
EBIT	$ -213.54M	$ -139.89M	$ -120.76M	$ -166.63M	$ -197.62M
EBITDA	$ -210.64M	$ -135.87M	$ -116.36M	$ -162.04M	$ -183.51M
Net Income Common Stockholders	$ -213.72M	$ -138.38M	$ -115.97M	$ -163.41M	$ -194.78M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 914.47M	$ 1.15B	$ 1.51B	$ 1.69B	$ 1.83B
Total Assets	$ 1.50B	$ 1.67B	$ 1.92B	$ 2.04B	$ 2.24B
Total Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Net Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Total Liabilities	$ 257.63M	$ 235.88M	$ 328.82M	$ 369.81M	$ 433.67M
Stockholders Equity	$ 1.24B	$ 1.43B	$ 1.59B	$ 1.68B	$ 1.81B
Cash Flow	-
Free Cash Flow	$ -173.83M	$ -78.13M	$ -109.46M	$ -159.54M	$ -398.70M
Operating Cash Flow	$ -171.48M	$ -77.85M	$ -107.93M	$ -155.83M	$ -389.25M
Investing Cash Flow	$ 118.60M	$ 211.61M	$ -104.81M	$ -58.95M	$ 230.31M
Financing Cash Flow	$ 31.00K	$ 2.94M	$ 1.68M	$ 277.00K	$ 3.18M

Currency in USD

Vir Biotechnology Earnings and Revenue History

Income Statement >

Vir Biotechnology Debt to Assets

Balance Sheet >

Vir Biotechnology Cash Flow

Cash Flow >

Vir Biotechnology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing